Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Xianbin WuRunkun HanYanping ZhongNuoqing WengAo ZhangPublished in: Cancer cell international (2021)
NLR at 6 weeks post treatment is a predictor of the response to anti-PD-1 treatment in patients with ESCC.